Roflumilast 500 mg Tablets by Novadoz Pharma (RX)
Roflumilast Tablets are an oral medication primarily used to manage and treat severe chronic obstructive pulmonary disease (COPD). They work as phosphodiesterase-4 (PDE4) inhibitors, helping to reduce inflammation in the lungs and decrease the frequency of COPD exacerbations or flare-ups. Roflumilast is typically prescribed for patients with a history of chronic bronchitis and aimed at improving lung function and breathing difficulties. This medication is often part of a comprehensive treatment plan that includes lifestyle changes and other medications.
Introducing Roflumilast 500 mg Tablets by Novadoz Pharma – a trusted advancement in chronic obstructive pulmonary disease (COPD) management. Crafted with precision, our high-quality medication is dedicated to enhancing lung function and ultimately improving quality of life for those battling COPD. Each tablet is designed to provide effective maintenance treatment, reducing the risk of COPD exacerbations and ensuring better patient outcomes.
Product Details and Features:
Active Ingredient: Roflumilast, a selective phosphodiesterase-4 (PDE4) inhibitor.
Strength: 500 mg per tablet.
Formulation: Easy-to-swallow oral tablet.
Packaging: Available in blister packs for enhanced protection and preservation, ensuring efficacy is maintained from our manufacturing facilities to your medicine cabinet.
Certification: Manufactured in accordance with the highest pharmaceutical standards and guidelines, ensuring purity, safety, and potency.
Targeted Use: Ideal for adults with severe COPD who suffer from chronic bronchitis and have a history of frequent exacerbations.
Mechanism of Action:
Roflumilast works by inhibiting phosphodiesterase-4 (PDE4) enzymes found in various inflammatory and immune cells. Inhibiting PDE4 leads to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels, which results in the suppression of the inflammatory response associated with COPD. This broad-spectrum anti-inflammatory effect helps to reduce inflammation in the lungs, leading to decreased frequency and severity of COPD flare-ups, improved lung function, and better respiratory health overall.
Directions:
- Take one tablet orally once a day, with or without food, or as directed by your healthcare provider.
- It is advisable to administer the tablet at the same time each day to maintain consistent blood levels of the medication.
- Swallow the tablet whole with a glass of water; do not crush, chew, or break the tablet.
- If a dose is missed, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double doses.
Warnings:
- Roflumilast is not indicated for the relief of acute bronchospasm or to manage sudden breathing problems.
- Patients with moderate to severe liver impairment should not use Roflumilast due to increased risk of side effects.
- It is essential to inform your healthcare provider of your full medical history, especially if you have a history of mental health issues such as depression and suicidal thoughts.
- Caution is advised when using this medication in conjunction with other medications that may also contribute to weight loss.
- Pregnant or breastfeeding women should consult their healthcare professional prior to initiating treatment with Roflumilast.
Side Effects:
While Roflumilast is well-tolerated by most patients, some individuals may experience side effects. Common side effects include:
- Weight loss
- Diarrhea
- Nausea
- Headache
- Loss of appetite
- Back pain
Serious side effects are rare but may include mental health changes such as depression or suicidal thoughts. If you experience any severe or concerning symptoms, seek medical attention immediately.
Note: This information is provided as an educational guide for Roflumilast 500 mg Tablets by Novadoz Pharma. Always consult your healthcare provider to ensure the information displayed on this document applies to your personal circumstances.
